Contrast Sensitivity in Glaucoma

NCT00947869 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2009-07-28

No results posted yet for this study

Summary

The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity. No therapeutic studies are performed.

Conditions

  • Primary Open Angle Glaucoma
  • Secondary Open Angle Glaucoma Due to PEX

Sponsors & Collaborators

  • University of Erlangen-Nürnberg

    lead OTHER

Principal Investigators

  • Anselm G Juenemann, Prof. · University Erlangen-Nuremberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00947869 on ClinicalTrials.gov